Stereoselective total synthesis of cis- and trans-3-hydroxypipecolic acid

Journal of Organic Chemistry

Volumn 70, Issue 24, 2005, Pages 10182-10185

  Liang, Ningning ^a   Datta, Apurba ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; CATALYST SELECTIVITY; CHELATION; MOLECULAR STRUCTURE; REDUCTION; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

3-HYDROXYPIPECOLIC ACID; ALCOHOL DERIVATIVES; STEREOSELECTIVITY;

AMINO ACIDS;

3 HYDROXYPIPECOLIC ACID; ALPHA AMINO ACID; AMINOALCOHOL; AMINOKETONE; BORANE DERIVATIVE; GRIGNARD REAGENT; PIPECOLIC ACID DERIVATIVE; REAGENT; SERINE; UNCLASSIFIED DRUG; ZINC; ZINC BOROHYDRIDE;

ARTICLE; CHELATION; CYCLIZATION; DEOXYGENATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROLYSIS; OXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REDUCTION; STEREOCHEMISTRY;

MOLECULAR STRUCTURE; PICOLINIC ACIDS; STEREOISOMERISM;

EID: 28044433662     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo051725u     Document Type: Article

References (43)

1. (a) Fodor, G. B.; Colasanti, B. The Pyridine and Piperidine Alkaloids: Chemistry and Pharmacology. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Wiley-Interscience: New York, 1985; Vol. 3, pp 1.
2. (b) Schneider, M. J. Pyridine and Piperidine Alkaloids: An Update. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Pergamon: Oxford, 1996; Vol. 10, p 155.
3. (c) Morton, T. C. Biochem. Syst. Ecol. 1998, 26, 379.
4. (d) Zografou, E. N.; Tsiropoulos, G. J.; Margaritas, L. H. Entomol. Exp. Appl. 1998, 87, 125.
5. For some leading references, see: (a) Sugisaki, C. H.; Caroll, P. J.; Correia, C. R. D. Tetrahedron Lett. 1998, 39, 3413.
6. (b) Copeland, T. D.; Wondrak, E. M.; Toszer, J.; Roberts, M. M.; Oraszan, S. Biochem. Biophys. Res. Commun. 1990, 169, 310.
7. (c) Hanesian, S.; McNaughton-Smith, G.; Lombart, H.-G.; Lubell, W. D. Tetrahedron 1997, 53, 12789.
8. (d) Mahara, G. M.; Marshall, G. R. Tetrahedron Lett. 1997, 38, 5069.
9. (a) Botman, P. N. M.; Dommerholt, F. J.; de Gelder, R.; Broxterman, Q. B.; Schoemaker, H. E.; Rutjes, F. P. J. T.; Blaauw, R. H. Org. Lett. 2004, 6, 4941.
10. (b) Brooks, C. A.; Comins, D. L. Tetrahedron Lett. 2000, 41, 3551.
11. (c) Haddad, M.; Larcheveque, M. Tetrahedron: Asymmetry 1999, 10, 4231.
12. (d) Gillard, J.; Abraham, A.; Anderson, P. C.; Beaulieu, P. L.; Bogri, T.; Bousquet, Y.; Grenier, L.; Guse, I.; Lavallée, P. J. Org. Chem. 1996, 61, 2226, and references therein.
13. For some recent synthetic studies, see: (a) Kumar, P.; Bodas, M. S. J. Org. Chem. 2005, 70, 360.
14. (b) Bodas, M. S.; Kumar, P. Tetrahedron Lett. 2004, 45, 8461.
15. (c) Koulocheri, S. D.; Magiatis, P.; Skaltsounis, A.-L.; Haroutounian, S. A. Tetrahedron 2002, 58, 6665.
16. (d) Haddad, M.; Larcheveque, M. Tetrahedron Lett. 2001, 42, 5223.
17. (e) Jourdant, A.; Zhu, J. Tetrahedron Lett. 2000, 41, 7033.
18. (f) Horikawa, M.; Busch-Petersen, J.; Corey, E. J. Tetrahedron Lett. 1999, 40, 3843.
19. (g) Scott, J. D.; Tippie, T. N.; Williams, R. M. Tetrahedron Lett. 1998, 39, 3659.
20. (h) Battistini, L.; Zanardi, F.; Rassu, G.; Spanu, P.; Pelosi, G.; Fava, G. G.; Ferrari, M. B.; Casiraghi, G. Tetrahedron: Asymmetry 1997, 8, 2975.
21. Agami, C.; Couty, F.; Mathieu, H. Tetrahedron Lett. 1996, 37, 4001 and references therein.
22. For representative examples, see; (a) Dragovich, P. S.; Parker, J. E.; Incacuan, M.; Kalish, V. J.; Kissinger, C. R.; Knighton, D. R.; Lewis, C. T.; Moomaw, E. W.; Parge, H. E.; Pelletier, L. A. K.; Prins, T. J.; Showalter, R. E.; Tatlock, J. H.; Tucker, K. D.; Villafranca, J. E. J. Med. Chem. 1999, 39, 1872.
23. (b) Shilvoek, J. P.; Nash, R. J.; Lloyd, J. D.; Winters, A. L.; Asano, N.; Fleet, J. W. Tetrahedron: Asymmetry 1998, 9, 3505.
24. (c) Ho, B.; Zabriskie, T. M. Bioorg. Med. Chem. Lett. 1998, 8, 739.
25. (d) Ninomiya, I.; Kiguchi, T.; Naito, T. Alkaloids 1998, 50, 317.
26. (e) Lamarre, D.; Croteau, G.; Bourgon, L.; Thibeult, D.; Wardrop, E.; Clouette, C.; Vaillancourt, M.; Cohen, E.; Pargellis, C.; Yoakim, C.; Anderson, P. C. Antimicrob. Agents Chemother. 1997, 41, 965.
27. (f) Skiles, J. W.; Giannousis, P. P.; Fales, K. R. Bioorg. Med. Chem. Lett. 1996, 6, 963 and references therein.
28. Ferreira, F.; Greek, C.; Genet, J. P. Bull. Soc. Chim. Fr. 1997, 134, 615.
29. For some recent examples, see: (a) Bhaket, P.; Morris, K.; Stauffer, C. S.; Datta, A. Org. Lett. 2005, 7, 875.
30. (b) Bhaket, P.; Stauffer, C. S.; Datta, A. J. Org. Chem. 2004, 69, 8594.
31. (c) Khalaf, J. K.; Datta, A. J. Org. Chem. 2004, 69, 387 and references therein.
32. Avenoza, A.; Cativiela, C.; Corzana, F.; Peregrina, J. M.; Zurbano, M. M. Synthesis 1997, 1146.
33. For representative examples, see: (a) Datta, A.; Veeresa, G. J. Org. Chem. 2000, 65, 7609.
34. (b) Kiran Kumar, K.; Datta, A. Tetrahedron 1999, 55, 13899.
35. Ravi Kumar, J. S.; Datta, A. Tetrahedron Lett. 1999, 40, 1381 and references therein. For a pioneering report,
36. see: Denis, J.-N.; Correa, A.; Greene, A. E. J. Org. Chem. 1991, 56, 6939.
37. Datta, A.; Ravi Kumar, J. S.; Roy, S. Tetrahedron 2001, 57, 1169.
38. Zhong, Y.-L.; Shing, T. K. M. J. Org. Chem. 1997, 62, 2622.
39. Pedregal, C.; Ezquerra, J.; Escribano, A.; Carreno, M. C.; Ruano, J. L. G. Tetrahedron Lett. 1994, 35, 2053.
40. Nelson, T. D.; Crouch, R. D. Synthesis 1996, 1031-1069.
41. Merino, P.; Lanaspa, A.; Merchan, F. L.; Tejero, T. Tetrahedron: Asymmetry 1998, 9, 629.
42. One of the reviewers of the manuscript wondered why the free secondary hydroxy group (at C-3) of compound 9, generated during the conversion of 8 → 9, did not undergo further oxidation to the corresponding ketone derivative. A couple of plausible explanations could be as follows: (i) the relatively short reaction time employed for the conversion of 8 → 9 (30 min) could probably be insufficient for carrying out the two-step process of initial cleavage of the silyl protecting group to unmask the hydroxy and subsequent oxidation of this relatively hindered secondary hydroxy to the corresponding ketone. (ii) A second possibility could be an intramolecular hydrogen bond interaction between the favorably placed (and newly generated) carboxylic acid moiety at C-2 and the free hydroxy group at C-3 of compound 9, resulting in the prevention or rate retardation of the oxidation of the hydroxy group. However, additional experiments will have to be carried out to find out the exact reason for the above reaction stopping at product 9.
43. Collier, P. N.; Campbell, A. D.; Patel, I.; Raynham, T. M.; Taylor, R. J. K. J. Org. Chem. 2002, 67, 1802.